Loading clinical trials...
Loading clinical trials...
Clinical Characteristics, Prognosis and Prognostic Model of Pediatric Immune Thrombocytopenia: a Prospective, Multicenter, Observational Cohort Study
Conditions
Interventions
data collection
Locations
1
China
Chinese Academy of Medical Science and Blood Disease Hospital
Tianjin, China
Start Date
November 1, 2023
Primary Completion Date
December 1, 2026
Completion Date
December 1, 2036
Last Updated
February 11, 2026
NCT05070845
NCT07039422
NCT06888960
NCT06594146
NCT07421167
NCT07083739
Lead Sponsor
Institute of Hematology & Blood Diseases Hospital, China
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions